{
    "organizations": [],
    "uuid": "5224a343ddd499cac539f35d8300073c8d2b846a",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-vandas-hetlioz-demonstrates-effica/brief-vandas-hetlioz-demonstrates-efficacy-to-treat-jet-lag-disorder-idUSFWN1QN0EO",
    "ord_in_thread": 0,
    "title": "BRIEF-Vanda's Hetlioz Demonstrates Efficacy To Treat Jet Lag Disorder",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Vanda Pharmaceuticals Inc:\n* HETLIOZ® (TASIMELTEON) DEMONSTRATES EFFICACY TO TREAT JET LAG DISORDER IN AN 8 HOUR PHASE ADVANCE CLINICAL STUDY\n* VANDA PHARMACEUTICALS INC - ‍HETLIOZ DEMONSTRATED SIGNIFICANT AND CLINICALLY MEANINGFUL BENEFITS IN NIGHTTIME AND DAYTIME SYMPTOMS OF JET LAG DISORDER​\n* VANDA PHARMACEUTICALS - ‍RESULTS FROM JET8 STUDY SHOWED CLINICALLY MEANINGFUL EFFECTS OF HETLIOZ 20 MG ON PRIMARY ENDPOINT,MULTIPLE SECONDARY ENDPOINTS​\n* VANDA PHARMACEUTICALS INC - ‍INTENDS TO SEEK MARKETING APPROVAL FOR USE OF HETLIOZ IN TREATMENT OF JET LAG DISORDER​\n* VANDA PHARMACEUTICALS INC - ‍HETLIOZ DEMONSTRATES IMPROVEMENT IN TOTAL SLEEP TIME BY 85 MINUTES VERSUS PLACEBO IN STUDY​\n* VANDA PHARMACEUTICALS INC - ‍HETLIOZ DEMONSTRATES IMPROVEMENT IN NEXT DAY ALERTNESS VERSUS PLACEBO IN STUDY​ Source text for Eikon: Further company coverage:\n ",
    "published": "2018-03-05T20:12:00.000+02:00",
    "crawled": "2018-03-06T22:28:59.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "vanda",
        "pharmaceutical",
        "inc",
        "tasimelteon",
        "demonstrates",
        "efficacy",
        "treat",
        "jet",
        "lag",
        "disorder",
        "hour",
        "phase",
        "advance",
        "clinical",
        "study",
        "vanda",
        "pharmaceutical",
        "inc",
        "demonstrated",
        "significant",
        "clinically",
        "meaningful",
        "benefit",
        "nighttime",
        "daytime",
        "symptom",
        "jet",
        "lag",
        "vanda",
        "pharmaceutical",
        "jet8",
        "study",
        "showed",
        "clinically",
        "meaningful",
        "effect",
        "hetlioz",
        "mg",
        "primary",
        "endpoint",
        "multiple",
        "secondary",
        "vanda",
        "pharmaceutical",
        "inc",
        "seek",
        "marketing",
        "approval",
        "use",
        "hetlioz",
        "treatment",
        "jet",
        "lag",
        "vanda",
        "pharmaceutical",
        "inc",
        "demonstrates",
        "improvement",
        "total",
        "sleep",
        "time",
        "minute",
        "versus",
        "placebo",
        "vanda",
        "pharmaceutical",
        "inc",
        "demonstrates",
        "improvement",
        "next",
        "day",
        "alertness",
        "versus",
        "placebo",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}